Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OwletOWLT -2.31%59 Debt-to-EBITDA is 13.85 as of Jun. 2026. GuruFocus rates OWLT with a GF Score™ of 59/100 and a GF Value™ of $3.60 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 474 Medical Devices & Instruments companies, Owlet ranks worse than 210970.25% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Owlet's Debt-to-EBITDA or its related term are showing as below:
OWLT'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.5 Med: -0.47 Max: -0.21
Current: -3.15
During the past 6 years, the highest Debt-to-EBITDA Ratio of Owlet was -0.21. The lowest was -3.50. And the median was -0.47.
OWLT's Debt-to-EBITDA is ranked worse than 100% of 474
companies
in the Medical Devices & Instruments industry
Industry Median: 1.595
vs OWLT: -3.15
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Owlet Debt-to-EBITDA Related Terms
Owlet Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Owlet's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OWLT vs RCEL, APYX, INGN: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Owlet's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Owlet Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Owlet's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Owlet's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Owlet (OWLT) has a Debt-to-EBITDA of 13.85 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Owlet. According to the industry distribution chart, Owlet ranks #999999 out of 474 companies in the Medical Devices & Instruments industry.
Is Owlet's Debt-to-EBITDA too high?
Owlet's current Debt-to-EBITDA is 13.85. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.60. Owlet's value of 13.85 is 768.3% above this industry median. Based on the distribution chart, Owlet ranks #999999 out of 474 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Owlet has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Owlet's Debt-to-EBITDA compare to RCEL and APYX?
According to the Medical Devices & Instruments industry distribution chart, Owlet ranks #999999 out of 474 companies for Debt-to-EBITDA. This places Owlet in the lower half of its industry. The industry median Debt-to-EBITDA is 1.60. Owlet's value of 13.85 is 768.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.60, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Owlet's current Debt-to-EBITDA of 13.85 is 768.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Owlet. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Owlet's current Debt-to-EBITDA is 13.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Owlet stock overvalued right now?
Based on GuruFocus' analysis, Owlet (OWLT) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.60, compared to a current price of $5.08 — trading 41.1% above its estimated fair value. The current Debt-to-EBITDA is 13.85 and 768.3% above the Medical Devices & Instruments industry median of 1.60. Owlet's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Owlet (OWLT), the current Debt-to-EBITDA is 13.85 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Owlet (OWLT) Overvalued in 2026?
Based on GuruFocus' analysis, Owlet stock appears to be overvalued.
The current stock price of $5.08 is trading 41.1% above its estimated GF Value™ of $3.60.
GuruFocus considers Owlet to be Significantly Overvalued.
Key valuation signals for OWLT:
Debt-to-EBITDA: 13.85
GF Value™: $3.60 vs. price of $5.08 (41.1% above fair value)
Industry Position: 768.3% above the Medical Devices & Instruments median (#999999 of 474)
No single metric tells the full story. See the OWLT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.
59GF Score
Get the complete analysis for OWLT
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OWLT has been successfully added to your 
